The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...

AMD stock has declined in 2026, despite strong revenue growth and accelerating demand for its AI chips. AI infrastructure deals with Meta and OpenAI have improved AMD’s long-term revenue visibility.

Leveraging deep learning for immersive 3D visualization, integrated CT imaging workflows and enhanced precision in lung navigation and surgical planning L&T Technology Services Limited (BSE: 540115, ...

Leveraging deep learning for immersive 3D visualization, integrated CT imaging workflows and enhanced precision in lung navigation and surgical planning SAN JOSE ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

German Chancellor Friedrich Merz learned the wrong lesson on his recent trip to China. Advanced economies expand and remain competitive not through additional labor inputs but through capital ...

In order to strike a blistering 1,000 targets in the first 24 hours of its attack on Iran, the U.S. military leveraged the most advanced artificial intelligence it’s ever used in warfare, a tool that ...

We recently published 17 Stocks Jim Cramer Talked About. Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the stocks that Jim Cramer talked about. Chip designer Advanced Micro Devices, Inc. (NASDAQ ...

The Ford class of aircraft carriers is the latest addition to the US Navy's already formidable carrier fleet. Currently, the USS Gerald R. Ford is the only operational carrier from the class, although ...

Rei Penber is the Deputy Lead Editor for GameRant's Anime and Manga team, originally from Kashmir and currently based in Beirut. He brings seven years of professional experience as a writer and editor ...

California-based biotech Iovance Biotherapeutics announced today that its autologous tumor-infiltrating lymphocyte therapy lifileucel (Amtagvi) led to objective responses in 18 of the 41 patients (44% ...